Anthem Biosciences Plans RS 3,395 Cr IPO

Chandigarh, January 1, 2025: Anthem Biosciences Limited, an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing has…